Synthesis of novel arylaminoquinazolinylurea derivatives and their antiproliferative activities against bladder cancer cell line

Jung Hun Kim, Yeonui Kwak, Chiman Song, Eun Joo Roh, Chang Hyun Oh, So Ha Lee, Taebo Sim, Jung Hoon Choi, Kyung Ho Yoo

Research output: Contribution to journal › Article

1 Citation (Scopus)

Abstract

A novel series of arylurea and arylamide derivatives 1a–z, 2a–d having aminoquinazoline scaffold was designed and synthesized. Their in vitro antiproliferative activities against RT112 bladder cancer cell line and inhibitory activities against FGFR3 kinase were tested. Most compounds showed good antiproliferative activities against RT112 bladder cancer cell line, and arylurea compounds 1a–z were more potent than arylamide compounds 2a–d. Among them, eight compounds 1a, 1d–g, 1l, 1y, and 1z showed potent activities with GI50 values below submicromolar range. Especially, arylurea compounds 1d and 1g possessing 2,3-dimethyl and 3,4-dimethyl moieties exhibited superior or similar antiproliferative activity (GI50 = 8.8 nM and 30.2 nM, respectively) to AZD4547 (GI50 = 29.2 nM) as a reference standard.

Original languageEnglish
Pages (from-to)5082-5086
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume26
Issue number20
DOIs
Publication statusPublished - 2016 Oct 15

Fingerprint

Urinary Bladder Neoplasms
Cells
Derivatives
Cell Line
Scaffolds
Phosphotransferases
AZD4547
In Vitro Techniques

Keywords

  • Antiproliferative activity
  • Arylaminoquinazolinylamides
  • Arylaminoquinazolinylureas
  • Bladder cancer cell line
  • Enzymatic activity
  • FGFR3

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Synthesis of novel arylaminoquinazolinylurea derivatives and their antiproliferative activities against bladder cancer cell line. / Kim, Jung Hun; Kwak, Yeonui; Song, Chiman; Roh, Eun Joo; Oh, Chang Hyun; Lee, So Ha; Sim, Taebo; Choi, Jung Hoon; Yoo, Kyung Ho.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 26, No. 20, 15.10.2016, p. 5082-5086.

Research output: Contribution to journal › Article

Kim, JH, Kwak, Y, Song, C, Roh, EJ, Oh, CH, Lee, SH, Sim, T, Choi, JH & Yoo, KH 2016, 'Synthesis of novel arylaminoquinazolinylurea derivatives and their antiproliferative activities against bladder cancer cell line', Bioorganic and Medicinal Chemistry Letters, vol. 26, no. 20, pp. 5082-5086. https://doi.org/10.1016/j.bmcl.2016.08.076
Kim JH, Kwak Y, Song C, Roh EJ, Oh CH, Lee SH et al. Synthesis of novel arylaminoquinazolinylurea derivatives and their antiproliferative activities against bladder cancer cell line. Bioorganic and Medicinal Chemistry Letters. 2016 Oct 15;26(20):5082-5086. https://doi.org/10.1016/j.bmcl.2016.08.076
Kim, Jung Hun ; Kwak, Yeonui ; Song, Chiman ; Roh, Eun Joo ; Oh, Chang Hyun ; Lee, So Ha ; Sim, Taebo ; Choi, Jung Hoon ; Yoo, Kyung Ho. / Synthesis of novel arylaminoquinazolinylurea derivatives and their antiproliferative activities against bladder cancer cell line. In: Bioorganic and Medicinal Chemistry Letters. 2016 ; Vol. 26, No. 20. pp. 5082-5086.
@article{499bfab83dcd4e2cb64d58c1e971695e,
title = "Synthesis of novel arylaminoquinazolinylurea derivatives and their antiproliferative activities against bladder cancer cell line",
abstract = "A novel series of arylurea and arylamide derivatives 1a–z, 2a–d having aminoquinazoline scaffold was designed and synthesized. Their in vitro antiproliferative activities against RT112 bladder cancer cell line and inhibitory activities against FGFR3 kinase were tested. Most compounds showed good antiproliferative activities against RT112 bladder cancer cell line, and arylurea compounds 1a–z were more potent than arylamide compounds 2a–d. Among them, eight compounds 1a, 1d–g, 1l, 1y, and 1z showed potent activities with GI50 values below submicromolar range. Especially, arylurea compounds 1d and 1g possessing 2,3-dimethyl and 3,4-dimethyl moieties exhibited superior or similar antiproliferative activity (GI50 = 8.8 nM and 30.2 nM, respectively) to AZD4547 (GI50 = 29.2 nM) as a reference standard.",
keywords = "Antiproliferative activity, Arylaminoquinazolinylamides, Arylaminoquinazolinylureas, Bladder cancer cell line, Enzymatic activity, FGFR3",
author = "Kim, {Jung Hun} and Yeonui Kwak and Chiman Song and Roh, {Eun Joo} and Oh, {Chang Hyun} and Lee, {So Ha} and Taebo Sim and Choi, {Jung Hoon} and Yoo, {Kyung Ho}",
year = "2016",
month = "10",
day = "15",
doi = "10.1016/j.bmcl.2016.08.076",
language = "English",
volume = "26",
pages = "5082--5086",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "20",

}

TY - JOUR

T1 - Synthesis of novel arylaminoquinazolinylurea derivatives and their antiproliferative activities against bladder cancer cell line

AU - Kim, Jung Hun

AU - Kwak, Yeonui

AU - Song, Chiman

AU - Roh, Eun Joo

AU - Oh, Chang Hyun

AU - Lee, So Ha

AU - Sim, Taebo

AU - Choi, Jung Hoon

AU - Yoo, Kyung Ho

PY - 2016/10/15

Y1 - 2016/10/15

N2 - A novel series of arylurea and arylamide derivatives 1a–z, 2a–d having aminoquinazoline scaffold was designed and synthesized. Their in vitro antiproliferative activities against RT112 bladder cancer cell line and inhibitory activities against FGFR3 kinase were tested. Most compounds showed good antiproliferative activities against RT112 bladder cancer cell line, and arylurea compounds 1a–z were more potent than arylamide compounds 2a–d. Among them, eight compounds 1a, 1d–g, 1l, 1y, and 1z showed potent activities with GI50 values below submicromolar range. Especially, arylurea compounds 1d and 1g possessing 2,3-dimethyl and 3,4-dimethyl moieties exhibited superior or similar antiproliferative activity (GI50 = 8.8 nM and 30.2 nM, respectively) to AZD4547 (GI50 = 29.2 nM) as a reference standard.

AB - A novel series of arylurea and arylamide derivatives 1a–z, 2a–d having aminoquinazoline scaffold was designed and synthesized. Their in vitro antiproliferative activities against RT112 bladder cancer cell line and inhibitory activities against FGFR3 kinase were tested. Most compounds showed good antiproliferative activities against RT112 bladder cancer cell line, and arylurea compounds 1a–z were more potent than arylamide compounds 2a–d. Among them, eight compounds 1a, 1d–g, 1l, 1y, and 1z showed potent activities with GI50 values below submicromolar range. Especially, arylurea compounds 1d and 1g possessing 2,3-dimethyl and 3,4-dimethyl moieties exhibited superior or similar antiproliferative activity (GI50 = 8.8 nM and 30.2 nM, respectively) to AZD4547 (GI50 = 29.2 nM) as a reference standard.

KW - Antiproliferative activity

KW - Arylaminoquinazolinylamides

KW - Arylaminoquinazolinylureas

KW - Bladder cancer cell line

KW - Enzymatic activity

KW - FGFR3

UR - http://www.scopus.com/inward/record.url?scp=84988911818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988911818&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2016.08.076

DO - 10.1016/j.bmcl.2016.08.076

M3 - Article

C2 - 27599742

AN - SCOPUS:84988911818

VL - 26

SP - 5082

EP - 5086

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 20

ER -

Access to Document